Internal Medicine, Gastroenterology · Lowell, MA
NPI
1346336831
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
41 Wellman St Ste 400
Lowell, MA, 01851
Phone (978) 459-6737
Groups this clinician bills Medicare through
Medicare paid, 2024
$124K
2,232 services
Medicare patients, 2024
664
Average age 71
Drug cost, 2024
$1.2M
983 prescriptions
Company payments, 2025
$1,923
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard S Tilson was code 99214 (office e&m - established), 258 times for 197 patients. In total Richard S Tilson billed 2,232 services in 47 codes, and Medicare paid $124K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 258 | 197 | $100.79 | $26K |
| 45385 Colonoscopy - Lesion Removal | Facility | 126 | 125 | $171.68 | $22K |
| 99204 Office E&M - New | Office | 111 | 111 | $123.84 | $14K |
| 43239 Upper GI Endoscopy | Facility | 91 | 87 | $75.71 | $6,889 |
| 99222 Hospital E&M - Initial | Facility | 42 | 42 | $101.29 | $4,254 |
| 99223 Hospital E&M - Initial | Facility | 40 | 40 | $129.28 | $5,171 |
| 45380 Lower GI Endoscopy - Other | Facility | 39 | 39 | $85.19 | $3,323 |
| 43235 Upper GI Endoscopy | Facility | 32 | 31 | $89.13 | $2,852 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 30 | 30 | $182.30 | $5,469 |
| 76981 Ultrasound - Nonspecific | Office | 24 | 24 | $82.05 | $1,969 |
| 99203 Office E&M - New | Office | 22 | 22 | $81.65 | $1,796 |
| 99233 Hospital E&M - Subsequent | Facility | 21 | 17 | $90.31 | $1,897 |
| 45378 Lower GI Endoscopy - Other | Facility | 20 | 19 | $95.77 | $1,915 |
| 99213 Office E&M - Established | Office | 19 | 19 | $68.28 | $1,297 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 15 | 15 | $178.54 | $2,678 |
By year: 2022 $107K for 1,394 services; 2023 $110K for 1,708 services; 2024 $124K for 2,232 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard S Tilson prescribed most often to Medicare patients was Omeprazole, with 173 prescriptions and refills. In total Richard S Tilson wrote 983 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 173 | 485 | 76 | $3,461 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 97 | 97 | 92 | $16K |
| Pantoprazole Sodium Generic | 76 | 207 | 36 | $1,662 |
| Linzess Linaclotide | 57 | 81 | 15 | $46K |
| Dicyclomine Hcl Generic | 57 | 131 | 24 | $1,782 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 44 | 44 | 43 | $2,805 |
| Mesalamine Generic | 36 | 88 | 12 | $24K |
| Entyvio Vedolizumab | 35 | 44 | Under 11 | $312K |
| Famotidine Generic | 32 | 74 | 14 | $394 |
| Motegrity Prucalopride Succinate | 30 | 66 | Under 11 | $34K |
| Xifaxan Rifaximin | 22 | 22 | Under 11 | $62K |
| Stelara Ustekinumab | 21 | 35 | Under 11 | $582K |
| Ursodiol Generic | 18 | 52 | Under 11 | $4,054 |
| Vemlidy Tenofovir Alafenamide | 18 | 22 | Under 11 | $32K |
| Sucralfate Generic | 17 | 41 | Under 11 | $3,512 |
Brand drugs: 338 claims; generic drugs: 645 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard S Tilson $1,923 ($1,923 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $315.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 21 | $315 |
| Gilead Sciences, Inc. GILD | 10 | $235 |
| Pfizer Inc. PFE | 10 | $220 |
| Genzyme Corporation SNY | 7 | $187 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 12 | $177 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $176 |
| Janssen Biotech, Inc. JNJ | 6 | $142 |
| Phathom Pharmaceuticals, Inc. PHAT | 4 | $80.31 |
| Ardelyx, Inc. ARDX | 4 | $61.27 |
| NeurAxis, Inc. NRXS | 1 | $58.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.